About Uncommon Cures
A team built around rare disease clinical trials
Uncommon Cures is a rare disease development and execution partner built to help sponsors move from strategy to clinical readiness to trial execution through a patient-centered, physician-led model.
Who we are
Rare disease does not fit a standard clinical trial model
Uncommon Cures is focused on rare disease clinical trials.
We bring together scientific strategy, trial readiness, and hands-on execution under one model so programs can move forward with more continuity and less fragmentation. Our work is built around the realities of rare disease, where patient populations are small, timelines matter, and getting the trial right from the start can make a meaningful difference.
What sets Uncommon Cures apart
Our model is built specifically for the demands of rare disease clinical research.
Rare Disease Focus
Our model is built specifically for the scientific, operational, and patient recruitment realities that make rare disease trials fundamentally different.
Design + Execution Under One Model
We help shape the strategy and support delivery, so the intent behind the trial is not lost between planning and execution.
Physician-Led Leadership
Clinical insight stays connected to operational decision-making, helping programs move forward with stronger judgment and better alignment.
Patient-Centered Trial Planning
Patient and caregiver burden are considered from the beginning so studies are more practical, more accessible, and more likely to succeed.
Operational Readiness
We help turn strategy into a real-world plan with the right structure, support, and preparation to move into clinic confidently.
Leadership
The team you work with
Our Board of Directors
Uncommon Cures is guided by an accomplished Board of Directors.
Years of Combined Experience
Efficiency Increase
Major Airports Nearby
Cups of Coffee Consumed
Our Leadership Model
Leadership that stays connected to delivery
At Uncommon Cures, the same experts who help shape the development approach remain connected to the work of delivering the study.
That continuity matters. It helps keep strategy practical, operations aligned, and execution grounded in the original intent of the program.
Our Approach
Built around rare disease realities
Traditional clinical trial approaches do not always fit the realities of rare disease. That is why our approach is built around the disease, the therapy, the patient population, and the practical experience of participation. We believe trial design should be scientifically strong, operationally realistic, and mindful of the burden placed on patients and families. Across design, readiness, and execution, our goal is the same: to help rare disease trials work in the real world.
